Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04073823 · ClinicalTrials.gov registry record · NA
A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema Patients
A NA study, sponsored by Tactile Medical.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04073823: Clinical Trial NA study, sponsored by Tactile Medical.
NCT04073823 is a NA study that was terminated before completion, run by Tactile Medical. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04073823, a NA study, was terminated before completion, sponsored by Tactile Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The objective of the study is to demonstrate equivalency in treatment effect, as determined by objective measurements, between the modified therapy cycle software and the FDA-cleared Flexitouch therapy cycle software.
Primary Outcome
Comparison of the change in the rate of lymphatic propulsion events from the pre-treatment values to the post-treatment values for both the affected and contralateral limbs using the investigational technique of near infrared-fluorescent (NIRF) imaging.
Interventions
- DEVICE Flexitouch Plus
- DEVICE Flexitouch Plus FT with software modification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-01-23 |
| Est. Completion | 2020-02-08 |
| Phase | NA |
Why NCT04073823 stopped before completion
NCT04073823 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Flexitouch Plus is the first listed.
NCT04073823 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04073823 about?
NCT04073823 is a clinical study titled "A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema Patients". The objective of the study is to demonstrate equivalency in treatment effect, as determined by objective measurements, between the modified therapy cycle software and the FDA-cleared Flexitouch therapy cycle software.
What is the current status of trial NCT04073823?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2020-01-23. Estimated completion is 2020-02-08.
What interventions are being tested in trial NCT04073823?
The interventions under investigation include: Flexitouch Plus (DEVICE), Flexitouch Plus FT with software modification (DEVICE).
Who is sponsoring clinical trial NCT04073823?
This trial is sponsored by Tactile Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04073823's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI